The clinical trial data visualization market, valued at $0.89 billion in 2025, is projected to grow to $1.03 billion by 2026 and further to $1.82 billion by 2030, with a CAGR of around 15.4-15.7%. Growth is fueled by increasing trial data complexity, expansion of decentralized trials, and rising demand for AI-driven and cloud-based analytics platforms. Key trends include interactive dashboards, real-time monitoring, and AI-enhanced data management, improving trial efficiency and decision-making. North America currently leads the market, while Asia-Pacific is expected to be the fastest-growing region through 2030.
Oracle shares recently dropped sharply amid market concerns despite $67 billion in AI deals and $70 billion planned spending. Historically, Oracle stock falls an average of 18% during market crises, worse than the S&P 500, with declines up to 40% in ...
Tradr ETFs has introduced two new leveraged ETFs that provide twice the inverse daily performance (-200%) of Applied Optoelectronics and Oracle stocks. These funds, listed on Cboe, offer traders tools to profit from or hedge against declines in these...
Oracle is transforming from a traditional software company into a hyperscaler focused on AI-driven cloud infrastructure. The company faces risks from high debt and customer concentration, notably with OpenAI, but its accelerating cloud revenue and la...
Oracle introduced a new AI Studio Skill within Oracle AI Agent Studio for Fusion Applications, enabling customers and partners to build AI-driven Fusion Agentic Applications natively inside Oracle Fusion Cloud. These applications use specialized AI a...
Bealls Inc., a 111-year-old US retailer, improved its clearance pricing strategy by adopting Oracle Retail Lifecycle Pricing Optimization (LPO). This AI-driven solution replaces fixed markdown schedules with dynamic pricing based on real-time demand,...
